Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anika Therapeutics (ANIK) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for Anika Therapeutics (ANIK) over the last 16 years, with Q3 2025 value amounting to $1.4 million.

  • Anika Therapeutics' Depreciation & Amortization (CF) fell 2521.51% to $1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.6 million, marking a year-over-year decrease of 1924.63%. This contributed to the annual value of $6.9 million for FY2024, which is 699.41% up from last year.
  • Latest data reveals that Anika Therapeutics reported Depreciation & Amortization (CF) of $1.4 million as of Q3 2025, which was down 2521.51% from $1.3 million recorded in Q2 2025.
  • In the past 5 years, Anika Therapeutics' Depreciation & Amortization (CF) ranged from a high of $1.9 million in Q3 2024 and a low of $1.3 million during Q2 2025
  • In the last 5 years, Anika Therapeutics' Depreciation & Amortization (CF) had a median value of $1.6 million in 2023 and averaged $1.6 million.
  • Data for Anika Therapeutics' Depreciation & Amortization (CF) shows a peak YoY increase of 18443.05% (in 2021) and a maximum YoY decrease of 5832.88% (in 2021) over the last 5 years.
  • Over the past 5 years, Anika Therapeutics' Depreciation & Amortization (CF) (Quarter) stood at $1.8 million in 2021, then fell by 3.26% to $1.7 million in 2022, then fell by 5.35% to $1.6 million in 2023, then dropped by 4.18% to $1.6 million in 2024, then dropped by 10.83% to $1.4 million in 2025.
  • Its Depreciation & Amortization (CF) was $1.4 million in Q3 2025, compared to $1.3 million in Q2 2025 and $1.4 million in Q1 2025.